NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss clinical-stage biopharmaceutical company focused on developing innovative ...

Marine Atlantic says that changing its rates to lower user costs amid a tumultuous on-again-off-again trade war between ...

NLS Pharmaceutics (NLSP) and Kadimastem, a clinical-stage company specializing in “off-the-shelf” allogeneic cell therapy products for ...

NLS Pharmaceutics (NLSP) announces new preclinical findings on AEX-2, reinforcing its potential as a first-in-class non-sulfonamide dual orexin ...

NLS Pharmaceutics ( ($NLSP) ) just unveiled an announcement. On February 25, 2025, NLS Pharmaceutics, in collaboration with ...

The under-13 AAA Scotiabank Puffins have had a successful year playing in the under-13 boys B Don Johnson Hockey League, but ...

Revolutionizing Diabetes Treatment: Introduction of cutting-edge, multi-targeted innovation to transform diabetes care. Diabetes more than just a Metabolic Disorder: Diabetes is a multi-systemic ...

MARSHALL — The Minnewaska girls basketball team relied on its offensive rebounding and gritty, aggressive defense to knock ...

Indore: India must harness the transformative potential of laser technology to drive innovation and self-reliance in ...

NLS Pharmaceutics Ltd., in collaboration with Aexon Labs Inc., has announced new preclinical findings on AEX-2, a non-sulfonamide dual orexin receptor agonist (DOXA) with potential for narcolepsy and ...